REQUEST A DEMO
Total
USD $0.00
Search more companies

Frontier Biopharma Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Pharmaceutical Preparation Manufacturing | Merchant Wholesalers, Durable Goods | Warehousing and Storage | Advertising Agencies | Other Services Related to Advertising | Marketing Research and Public Opinion Polling | All Other Support Services
Full name: Frontier Biopharma Sp. z o.o. Profile Updated: July 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Frontier Biopharma Sp. z o.o. is an enterprise located in Poland, with the main office in Warsaw. The company operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers sector. It was established on August 22, 2022. A growth of 600.19% was recorded in its total assets.

Headquarters
Ul. Grzybowska 2/29
Warsaw; Mazowieckie; Postal Code: 00-131

Contact Details: Purchase the Frontier Biopharma Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Frontier Biopharma Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Frontier Biopharma Sp. z o.o. report to view the information.
Incorporation Date:
August 22, 2022
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Frontier Biopharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
600.19%
Total equity
10.46%
Return on Equity (ROE)
N/A
Quick Ratio
-0.39%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?